| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Denise C Vidot, Sapna Deo, Sylvia Daunert, Willie L Joseph, Nestor de la Cruz-Munoz, Sarah E Messia. A Preliminary Study on the Influence of Cannabis and Opioid Use on Weight Loss and Mental Health Biomarkers Post-weight Loss Surgery. Obesity surgery. vol 30. issue 11. 2021-04-14. PMID:32860570. |
this study examined the influence of the independent and combined use of cannabis and opioids on (1) depression and anxiety, (2) duodenum serotonin and cortisol, and (3) total percent weight loss. |
2021-04-14 |
2023-08-13 |
Not clear |
| Carolina Echeverry, Giselle Prunell, Camila Narbondo, Verónica Sánchez de Medina, Xavier Nadal, Miguel Reyes-Parada, Cecilia Scorz. A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT Neurotoxicity research. vol 39. issue 2. 2021-03-10. PMID:32886342. |
a comparative in vitro study of the neuroprotective effect induced by cannabidiol, cannabigerol, and their respective acid forms: relevance of the 5-ht previous preclinical studies have demonstrated that cannabidiol (cbd) and cannabigerol (cbg), two non-psychotomimetic phytocannabinoids from cannabis sativa, induce neuroprotective effects on toxic and neurodegenerative processes. |
2021-03-10 |
2023-08-13 |
Not clear |
| Odunayo Anthonia Taiwo, Oluwatosin Adebisi Dosumu, Regina Ngozi Ugbaja, Solomon Oladapo Rotimi, Oluwafemi Paul Owolabi, Oluwafemi Adeleke Oj. Oral administration of marijuana produces alterations in serotonin 5-hydroxytryptamine receptor 3A gene ( Molecular biology research communications. vol 10. issue 1. 2021-03-10. PMID:33681392. |
oral administration of marijuana produces alterations in serotonin 5-hydroxytryptamine receptor 3a gene ( the gene expression of serotonin 5-hydroxytryptamine receptor 3a (receptor 3a: |
2021-03-10 |
2023-08-13 |
Not clear |
| Zackary T Montoya, Amy L Uhernik, Jeffrey P Smit. Comparison of cannabidiol to citalopram in targeting fear memory in female mice. Journal of cannabis research. vol 2. issue 1. 2021-02-06. PMID:33526146. |
cannabidiol (cbd) and selective serotonin reuptake inhibitors (ssris) are currently used to treat post-traumatic stress disorder (ptsd). |
2021-02-06 |
2023-08-13 |
mouse |
| Daniel Feingold, Aviv Weinstei. Cannabis and Depression. Advances in experimental medicine and biology. vol 1264. 2021-02-03. PMID:33332004. |
there is an indication for potential genetic correlation contributing to the comorbidity of cannabis dependence and major depression, namely that serotonin (5-ht) may mediate such association and there is also evidence for specific risk alleles for cannabis addiction. |
2021-02-03 |
2023-08-13 |
Not clear |
| Jacob W Baltz, Lamanh T L. Serotonin Syndrome versus Cannabis Toxicity in the Emergency Department. Clinical practice and cases in emergency medicine. vol 4. issue 2. 2021-01-10. PMID:32426664. |
serotonin syndrome versus cannabis toxicity in the emergency department. |
2021-01-10 |
2023-08-13 |
Not clear |
| Jacob W Baltz, Lamanh T L. Serotonin Syndrome versus Cannabis Toxicity in the Emergency Department. Clinical practice and cases in emergency medicine. vol 4. issue 2. 2021-01-10. PMID:32426664. |
therefore, marijuana toxicity should be considered in ed patients who present with signs and symptoms similar to that of serotonin syndrome. |
2021-01-10 |
2023-08-13 |
Not clear |
| Christopher Martínez-Aguirre, Francia Carmona-Cruz, Ana Luisa Velasco, Francisco Velasco, Gustavo Aguado-Carrillo, Manola Cuéllar-Herrera, Luisa Roch. Cannabidiol Acts at 5-HT Frontiers in behavioral neuroscience. vol 14. 2021-01-02. PMID:33384591. |
cannabidiol acts at 5-ht experimental evidence indicates that cannabidiol (cbd) induces anxiolytic and antiepileptic effects through the activation of 5-ht |
2021-01-02 |
2023-08-13 |
Not clear |
| Erin M Rock, Megan T Sullivan, Stephen A Collins, Hannah Goodman, Cheryl L Limebeer, Raphael Mechoulam, Linda A Parke. Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews. Psychopharmacology. vol 237. issue 9. 2020-12-23. PMID:32488349. |
when acutely administered intraperitoneally, the non-psychoactive cannabinoid cannabidiol (cbd), its acidic precursor cannabidiolic acid (cbda) and a stable methyl ester of cbda (hu-580) reduce lithium chloride (licl)-induced conditioned gaping in male rats (a selective preclinical model of acute nausea) via activation of the serotonin 1a (5-ht |
2020-12-23 |
2023-08-13 |
rat |
| Nicola Maggio, Efrat Shavit Stein, Menahem Sega. Cannabidiol Regulates Long Term Potentiation Following Status Epilepticus: Mediation by Calcium Stores and Serotonin. Frontiers in molecular neuroscience. vol 11. 2020-09-30. PMID:29467619. |
cannabidiol regulates long term potentiation following status epilepticus: mediation by calcium stores and serotonin. |
2020-09-30 |
2023-08-13 |
mouse |
| Janitza L Montalvo-Ortiz, Hang Zhou, Ivana D'Andrea, Luc Maroteaux, Adriana Lori, Alicia Smith, Kerry J Ressler, Yaira Z Nuñez, Lindsay A Farrer, Hongyu Zhao, Henry R Kranzler, Joel Gelernte. Translational studies support a role for serotonin 2B receptor (HTR2B) gene in aggression-related cannabis response. Molecular psychiatry. vol 23. issue 12. 2019-09-17. PMID:29875475. |
translational studies support a role for serotonin 2b receptor (htr2b) gene in aggression-related cannabis response. |
2019-09-17 |
2023-08-13 |
human |
| Danilo De Gregorio, Ryan J McLaughlin, Luca Posa, Rafael Ochoa-Sanchez, Justine Enns, Martha Lopez-Canul, Matthew Aboud, Sabatino Maione, Stefano Comai, Gabriella Gobb. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain. vol 160. issue 1. 2019-06-26. PMID:30157131. |
clinical studies indicate that cannabidiol (cbd), the primary nonaddictive component of cannabis that interacts with the serotonin (5-ht)1a receptor, may possess analgesic and anxiolytic effects. |
2019-06-26 |
2023-08-13 |
rat |
| Amanda J Sales, Carlos C Crestani, Francisco S Guimarães, Sâmia R L Joc. Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels. Progress in neuro-psychopharmacology & biological psychiatry. vol 86. 2019-04-15. PMID:29885468. |
antidepressant-like effect induced by cannabidiol is dependent on brain serotonin levels. |
2019-04-15 |
2023-08-13 |
mouse |
| Cheryl L Limebeer, Erin M Rock, Keith A Sharkey, Linda A Parke. Nausea-Induced 5-HT Release in the Interoceptive Insular Cortex and Regulation by Monoacylglycerol Lipase (MAGL) Inhibition and Cannabidiol. eNeuro. vol 5. issue 4. 2019-03-08. PMID:30073198. |
nausea-induced 5-ht release in the interoceptive insular cortex and regulation by monoacylglycerol lipase (magl) inhibition and cannabidiol. |
2019-03-08 |
2023-08-13 |
rat |
| Luis Arruza, Maria Ruth Pazos, Nagat Mohammed, Natalia Escribano, Hector Lafuente, Martín Santos, Francisco J Alvarez-Díaz, William Hind, Jose Martínez-Orgad. Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets. Pediatric research. vol 82. issue 1. 2018-06-21. PMID:28388598. |
we aimed to investigate the effects of cannabidiol (cbd) on lung damage in this scenario.methodsnewborn piglets received intravenous vehicle, cbd, or cbd+way100635 (5-ht |
2018-06-21 |
2023-08-13 |
Not clear |
| Jonathan L C Lee, Leandro J Bertoglio, Francisco S Guimarães, Carl W Stevenso. Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders. British journal of pharmacology. vol 174. issue 19. 2018-05-22. PMID:28268256. |
studies show that cannabidiol, the main non-psychotomimetic phytocannabinoid found in cannabis sativa, reduces anxiety via 5-ht |
2018-05-22 |
2023-08-13 |
Not clear |
| Roy Otten, Anja C Huizink, Karin Monshouwer, Hanneke E Creemers, Simone Onrus. Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene. Addiction biology. vol 22. issue 4. 2018-04-24. PMID:26860734. |
cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene. |
2018-04-24 |
2023-08-13 |
Not clear |
| Roy Otten, Anja C Huizink, Karin Monshouwer, Hanneke E Creemers, Simone Onrus. Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene. Addiction biology. vol 22. issue 4. 2018-04-24. PMID:26860734. |
the present study examines the relationship between cannabis use and symptoms of anxiety by taking a developmental molecular-genetic perspective with a focus on a polymorphism involved in the regulation of serotonin. |
2018-04-24 |
2023-08-13 |
Not clear |
| Lance R McMaho. Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys. Drug and alcohol dependence. vol 165. 2017-10-09. PMID:27289270. |
cannabidiol, a therapeutic with potential serotonin (5-hydroxytryptamine; 5-ht) 5-ht1a receptor agonist activity, is the second most prevalent cannabinoid in cannabis after Δ(9)-thc. |
2017-10-09 |
2023-08-13 |
monkey |
| Danielle N Rhyne, Sarah L Anderson, Margaret Gedde, Laura M Borgel. Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population. Pharmacotherapy. vol 36. issue 5. 2017-05-08. PMID:26749285. |
no clinical trials are currently available that demonstrate the effects of marijuana on patients with migraine headache; however, the potential effects of cannabinoids on serotonin in the central nervous system indicate that marijuana may be a therapeutic alternative. |
2017-05-08 |
2023-08-13 |
Not clear |